Hepatology, 1527-3350

Journal

More filtering options
  1. 2016
  2. A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice

    Peter Lundbäck, Jonathan D. Lea, Agnieszka Sowinska, Lars Ottosson, Camilla Melin Fürst, Johanna Steen, Cecilia Aulin, Joanna I. Clarke, Anja Kipar, Lena Klevenvall, Huan Yang, Karin Palmblad, B. Kevin Park, Kevin J. Tracey, Anna M. Blom, Ulf Andersson, Daniel J. Antoine & Helena Erlandsson Harris, 2016 Nov 1, In: Hepatology. 64, 5, p. 1699-1710 12 p.

    Research output: Contribution to journalArticle

  3. 2014
  4. CYLD regulates HGF expression in hepatic stellate cells via interaction with HDAC7.

    Pannem Rao Rajeswara, Christoph Dorn, Claus Hellerbrand & Ramin Massoumi, 2014, In: Hepatology. 60, 3, p. 1066-1081

    Research output: Contribution to journalArticle

  5. Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer

    Krasimira Aleksandrova, Heiner Boeing, Ute Noethlings, Mazda Jenab, Veronika Fedirko, Rudolf Kaaks, Annekatrin Lukanova, Antonia Trichopoulou, Dimitrios Trichopoulos, Paolo Boffetta, Elisabeth Trepo, Sabine Westhpal, Talita Duarte-Salles, Magdalena Stepien, Kim Overvad, Anne Tjonneland, Jytte Halkjaer, Marie-Christine Boutron-Ruault, Laure Dossus, Antoine Racine & 28 others, Pagona Lagiou, Christina Bamia, Vassiliki Benetou, Claudia Agnoli, Domenico Palli, Salvatore Panico, Rosario Tumino, Paolo Vineis, Bas Bueno-De-Mesquita, Petra H. Peeters, Inger Torhild Gram, Eiliv Lund, Elisabete Weiderpass, J. Ramon Quiros, Antonio Agudo, Maria-Jose Sanchez, Diana Gavrila, Aurelio Barricarte, Miren Dorronsoro, Bodil Ohlsson, Bjoern Lindkvist, Anders Johansson, Malin Sund, Kay-Tee Khaw, Nicholas Wareham, Ruth C. Travis, Elio Riboli & Tobias Pischon, 2014, In: Hepatology. 60, 3, p. 858-871

    Research output: Contribution to journalArticle

  6. Prediagnostic Circulating Vitamin D Levels and Risk of Hepatocellular Carcinoma in European Populations: A Nested Case-Control Study

    Veronika Fedirko, Talita Duarte-Salles, Christina Bamia, Antonia Trichopoulou, Krasimira Aleksandrova, Dimitrios Trichopoulos, Elisabeth Trepo, Anne Tjonneland, Anja Olsen, Kim Overvad, Marie-Christine Boutron-Ruault, Francoise Clavel-Chapelon, Marina Kvaskoff, Tilman Kuehn, Annie Lukanova, Heiner Boeing, Brian Buijsse, Eleni Klinaki, Chrysanthi Tsimakidi, Alessio Naccarati & 29 others, Giovanna Tagliabue, Salvatore Panico, Rosario Tumino, Domenico Palli, H. Bas Bueno-de-Mesquita, Peter D. Siersema, Petra H. Peters, Eiliv Lund, Magritt Brustad, Karina Standahl Olsen, Elisabete Weiderpass, Raul Zamora-Ros, Maria-Jose Sanchez, Eva Ardanaz, Pilar Amiano, Carmen Navarro, J. Ramon Quiros, Marten Werner, Malin Sund, Bjorn Lindkvist, Johan Malm, Ruth C. Travis, Kay-Tee Khaw, Magdalena Stepien, Augustin Scalbert, Isabelle Romieu, Pagona Lagiou, Elio Riboli & Mazda Jenab, 2014, In: Hepatology. 60, 4, p. 1222-1230

    Research output: Contribution to journalArticle

  7. The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis

    Darragh Duffy, Rasha Mamdouh, Melissa Laird, Charlotte Soneson, Lenaig Le Fouler, Mai El-Daly, Armanda Casrouge, Jeremie Decalf, Amal Abbas, Noha Sharaf Eldin, Magnus Fontes, Mohamed Abdel-Hamid, Mostafa K. Mohamed, Mona Rafik, Arnaud Fontanet & Matthew L. Albert, 2014, In: Hepatology. 59, 4, p. 1273-1282

    Research output: Contribution to journalArticle

  8. 2012
  9. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice

    Vladislav Volarevic, Marija Milovanovic, Biljana Ljujic, Nada Pejnovic, Nebojsa Arsenijevic, Ulf Nilsson, Hakon Leffler & Miodrag L. Lukic, 2012, In: Hepatology. 55, 6, p. 1954-1964

    Research output: Contribution to journalArticle

  10. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents

    Nicola Santoro, Clarence K. Zhang, Hongyu Zhao, Andrew J. Pakstis, Grace Kim, Romy Kursawe, Daniel J. Dykas, Allen E. Bale, Cosimo Giannini, Bridget Pierpont, Melissa M. Shaw, Leif Groop & Sonia Caprio, 2012, In: Hepatology. 55, 3, p. 781-789

    Research output: Contribution to journalArticle

  11. 2011
  12. IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection

    Amir Moghaddam, Espen Melum, Nils Reinton, Helmer Ring-Larsen, Hans Verbaan, Kristian Bjoro & Olav Dalgard, 2011, In: Hepatology. 53, 3, p. 746-754

    Research output: Contribution to journalArticle

  13. The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy.

    Per Levéen, Heike Kotarsky, Matthias Mörgelin, Riitta Karikoski, Eskil Elmer & Vineta Fellman, 2011, In: Hepatology. 53, 2, p. 437-447

    Research output: Contribution to journalArticle

  14. 2010
  15. Il28B Genetic Variation And Treatment Response In Patients With Hcv Genotype 3 Infection

    Olav Dalgard, Amir Moghaddam, Hans Verbaan, Helmer Ring-Larsen, Kristian Bjoro & Espen Melum, 2010, In: Hepatology. 52, 4, p. 898

    Research output: Contribution to journalPublished meeting abstract

  16. Incidence and Prevalence of Primary Sclerosing Cholangitis in a Defined Adult Population in Sweden

    Bjorn Lindkvist, Maria Benito de Valle, Bo Gullberg & Einar Bjornsson, 2010, In: Hepatology. 52, 2, p. 571-577

    Research output: Contribution to journalArticle

  17. Increased Factor Viii Activity In Portal Vein Thrombosis And Budd-Chiari Syndrome

    Rupesh Rajani, Annika Bergquist, Tor Melin, Ingalill Friis-Liby, Marjo Kapraali, Marten Werner, Per Sangfelt, Sven Wallerstedt, Tomas L. Lindahl & Sven Almer, 2010, In: Hepatology. 52, 4, p. 1217

    Research output: Contribution to journalPublished meeting abstract

  18. Minocycline Sensitizes Rodent and Human Liver Mitochondria to the Permeability Transition: Implications for Toxicity in Liver Transplantation

    Roland Månsson, Saori Morota, Magnus Hansson, Ichiro Sonoda, Yoshihiro Yasuda, Motohide Shimazu, Ayumu Sugiura, Shigeru Yanagi, Hitoshi Miura, Hiroyuki Uchino & Eskil Elmer, 2010, In: Hepatology. 51, 1, p. 347-348

    Research output: Contribution to journalLetter

  19. 2009
  20. Low-To-Moderate Alcohol Consumption has no Impact on Antiviral Response to Combination Therapy In Hcv Patients with Genotype 2 or 3

    Roberto J. Carvalho-Filho, Hans Verbaan, Kristian Bjoro, Helmer Ring-Larsen & Olav Dalgard, 2009, In: Hepatology. 50, 4, p. 819

    Research output: Contribution to journalPublished meeting abstract

  21. 2008
  22. IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

    Olav Dalgard, Hans Verbaan, Helmer Ring-Larsen & Kristian Bjoro, 2008, In: Hepatology. 48, 4, p. 1875

    Research output: Contribution to journalPublished meeting abstract

  23. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

    Olav Dalgard, Kristian Bjoro, Helmer Ring-Larsen, Einar Bjornsson, Mona Holberg-Petersen, Eva Skovlund, Olle Reichard, Bjorn Myrvang, Bo Sundelof, Stale Ritland, Kjell Hellum, Aril Fryden, Jon Florholmen & Hans Verbaan, 2008, In: Hepatology. 47, 1, p. 35-42

    Research output: Contribution to journalArticle

  24. 2006
  25. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation

    Hanne Prytz, Susanne Keiding, Einar Bjornsson, Ulrika Broome, Sven Ahner, Maria Castedal & Ole Lajord Munk, 2006, In: Hepatology. 44, 6, p. 1572-1580

    Research output: Contribution to journalArticle

  26. 2005
  27. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

    P Simmonds, J Bukh, C Combet, G Deleage, N Enomoto, S Feinstone, P Halfon, G Inchauspe, C Kuiken, G Maertens, M Mizokami, D G Murphy, H Okamoto, J M Pawlotsky, F O Penin, E Sablon, S I Tadasu, L Stuyver, H J Thiel, S Viazov & 2 others, A Weiner & Anders Widell, 2005, In: Hepatology. 42, 4, p. 962-973

    Research output: Contribution to journalArticle

  28. 2004
  29. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha(1)-antitrypsin.

    Sabina Janciauskiene, Sten Eriksson, Francesco Callea, Meera Mallya, Aiwu Zhou, Kuniaki Seyarna, Satoru Hata & David A. Lomas, 2004, In: Hepatology. 40, 5, p. 1203-1210

    Research output: Contribution to journalArticle

  30. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice

    S Oe, ER Lemmer, EA Conner, VM Factor, Per Levéen, Jonas Larsson, Stefan Karlsson & SS Thorgeirsson, 2004, In: Hepatology. 40, 5, p. 1098-1105

    Research output: Contribution to journalArticle

  31. 2003
  32. Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer.

    Torkel Wadström, Waleed Abu Al-Soud, Åsa Ljungh, Hans-Olof Nilsson & Unne Stenram, 2003, In: Hepatology. 38, 2, p. 532-533

    Research output: Contribution to journalLetter

  33. 2001
  34. Impact of selective inactivation of transforming growth factor-beta type II receptor gene (TGFBR2) during viral hepatitis

    E R Lemmer, E A Conner, P Leveen, V M Factor, T L Tsai, C G Huh, Stefan Karlsson & S S Thorgeirsson, 2001, In: Hepatology. 34, 4, Suppl. 2, p. 491A-491A

    Research output: Contribution to journalArticle

  35. 1997
  36. 1994
  37. Laser-induced Ala Photodynamic Therapy In the Treatment of Rat-liver Tumor

    D. L Liu, Katarina Svanberg, I Wang, Stefan Andersson-Engels, U Stenram & Sune Svanberg, 1994, In: Hepatology. 20, 4

    Research output: Contribution to journalArticle

  38. 1993
  39. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

    Yong-Yuan Zhang, Bengt-Göran Hansson, Lin Sheng Kuo, Anders Widell & Erik Nordenfelt, 1993, In: Hepatology. 17, 4, p. 538-544

    Research output: Contribution to journalArticle